BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20218099)

  • 1. Developments in therapeutic human papillomavirus vaccination.
    Albers AE; Siniković B; Banko AV; Jovanović S; Kaufmann AM
    Acta Chir Iugosl; 2009; 56(3):29-37. PubMed ID: 20218099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic human papillomavirus vaccination.
    Albers AE; Kaufmann AM
    Public Health Genomics; 2009; 12(5-6):331-42. PubMed ID: 19684445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Berman TA; Schiller JT
    Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines against human papillomavirus.
    Lin YY; Alphs H; Hung CF; Roden RB; Wu TC
    Front Biosci; 2007 Jan; 12():246-64. PubMed ID: 17127297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus in cervical and head-and-neck cancer.
    Psyrri A; DiMaio D
    Nat Clin Pract Oncol; 2008 Jan; 5(1):24-31. PubMed ID: 18097454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
    Yang A; Farmer E; Lin J; Wu TC; Hung CF
    Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
    Cheng MA; Farmer E; Huang C; Lin J; Hung CF; Wu TC
    Hum Gene Ther; 2018 Sep; 29(9):971-996. PubMed ID: 29316817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus therapeutic vaccines in head and neck tumors.
    Badaracco G; Venuti A
    Expert Rev Anticancer Ther; 2007 May; 7(5):753-66. PubMed ID: 17492938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
    Lee SJ; Yang A; Wu TC; Hung CF
    J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer: screening and prevention.
    Behtash N; Mehrdad N
    Asian Pac J Cancer Prev; 2006; 7(4):683-6. PubMed ID: 17250453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.
    Bacik LC; Chung C
    Int J Dermatol; 2018 Jun; 57(6):627-634. PubMed ID: 29152727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
    Tomson TT; Roden RB; Wu TC
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination Against Human Papilloma Viruses Leads to a Favorable Cytokine Profile of Specific T Cells.
    Luckau S; Wehrs TP; Brandau S; Horn PA; Lindemann M
    J Immunother; 2016 Oct; 39(8):316-20. PubMed ID: 27548034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
    Kaufmann AM; Backsch C; Schneider A; Dürst M
    Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in immunotherapy of cancers caused by human papillomaviruses.
    Fakhr E; Modic Ž; Cid-Arregui A
    Immunology; 2021 May; 163(1):33-45. PubMed ID: 33205441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.
    Skeate JG; Woodham AW; Einstein MH; Da Silva DM; Kast WM
    Hum Vaccin Immunother; 2016 Jun; 12(6):1418-29. PubMed ID: 26835746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
    Devaraj K; Gillison ML; Wu TC
    Crit Rev Oral Biol Med; 2003; 14(5):345-62. PubMed ID: 14530303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary, secondary and tertiary prevention of human papillomavirus-driven head and neck cancers.
    Mirghani H; Jung AC; Fakhry C
    Eur J Cancer; 2017 Jun; 78():105-115. PubMed ID: 28437708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.